News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Arch Pharmalabs Limited Announces Partnership With Orochem Technologies to Supply API for U.S. Innovator's Late-Stage Clinical Development Program



10/12/2009 9:08:25 AM

MADRID--(BUSINESS WIRE)--Arch Pharmalabs, Ltd., a leading provider of small molecule process R&D and full life-cycle custom synthesis and manufacturing services, announced today it has entered into a strategic partnership with Orochem Technologies, Inc., to manufacture a U.S. innovator’s active pharmaceutical ingredient (API) in late-stage clinical development using Simulated Moving Bed (SMB) technology. Orochem Technologies manufactures SMB equipment and stationary chromatography phases for Bioanalytical, Solid Phase Extraction, Flash and Preparative applications. Financial terms were not disclosed.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES